Monday, 31 August 2026European Markets

GPE GROUP PIZZORNO Stock Over 28% Up In The Last 21 Sessions

Loading stream...

(vianews) - shares of gpe group pizzorno (cac 40: gpe.pa) rose by a staggering 28.21% in 21 sessions from €42.9 to €55.00 at 17:52 est on wednesday, following the last session's downward trend. cac 40 is sliding 1.7% to €7,087.30, after two successive sessions in a row of losses.

about gpe group pizzorno

groupe pizzorno environnement provides environmental services primarily in france. it engages in the production and recycling of secondary raw materials; development of technologies and services for the recovery of bio-waste; production of heat and electricity from waste treatment; and processing and collection of household waste, as well as offers cleanliness services. groupe pizzorno environnement was founded in 1974 and is headquartered in draguignan, france.

earnings per share

as for profitability, gpe group pizzorno has a trailing twelve months eps of €4.89.

pe ratio

gpe group pizzorno has a trailing twelve months price to earnings ratio of 11.25. meaning, the purchaser of the share is investing €11.25 for every euro of annual earnings.

volume

today's last reported volume for gpe group pizzorno is 528 which is 10.2% above its average volume of 441.

more news about gpe group pizzorno (gpe.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com